|

One IM injection Lenti-HPV-07 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Theravectys S.A.1

Indications

  • HPV Positive Oropharyngeal Squamous Cell Carcinoma1
  • HPV-Related Cervical Carcinoma1
  • Cancer1

Orlando, Florida1 trial

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Florida Cancer Specialists (from Sarah Canon research Institute)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.